MENU
Aim higher

SimiQbD

Proof of Concept study for the development of a biosimilar monoclonal antibody using the Quality by Design (QbD) approach.

The project proposal is dealing with the development of a biosimilar Mab up to the stage of proof of concept. We propose a typical QbD approach for the development of our biosimilar Mab as is described in the recently published ‘A-Mab: a Case Study in Bioprocess Development’.
Acronym: 
SimiQbD
Project ID: 
5 690
Ranking: 
7
Cut-off: 
4
Start date: 
01-11-2010
Project Duration: 
24months
Project costs: 
1 556 200.00€
Technological Area: 
BIOLOGICAL SCIENCES / TECHNOLOGIES
Market Area: 
MEDICAL / HEALTH RELATED